Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.

Subjects

Subjects :

Antimetabolites, Antineoplastic therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Decitabine adverse effects
Humans
Treatment Outcome
Azacitidine therapeutic use
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute etiology

Details

Language :

English

ISSN :

1528-0020

Volume :

140

Issue :

3

Database :

MEDLINE

Journal :

Blood

Publication Type :

Academic Journal

Accession number :

35507690

Full Text :

https://doi.org/10.1182/blood.2022015832